Electrical stimulation and exercise for muscle loss in cirrhosis
Part of Brain & nervous system, Digestive system clinical trials.
This trial tests whether combining electrical stimulation with exercise can help hospitalized patients with alcoholic cirrhosis reduce muscle loss and improve strength. If you are in the hospital for cirrhosis caused by alcohol, this treatment might help you keep or regain muscle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently hospitalized with cirrhosis caused by alcohol.
- You have not lost too much leg strength (measured by a sit-to-stand test).
- You have not lost too much handgrip strength (men need at least 27 kgf, women at least 16 kgf).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special nutrition plan can help treat muscle loss in people with liver cirrhosis who also have fluid buildup that doesn't improve with standard treatment. It aims to improve strength and outcomes after a procedure to place a shunt in the liver.
This trial tests whether a muscle-stimulation device (using mild electrical pulses) can help people with sarcopenia (age-related muscle loss) regain strength. You'll also do an exercise program, and the study aims to see if this combination improves mobility and function.
This study tests whether a physical therapy program can help older adults with age-related muscle loss (sarcopenia) improve their strength and muscle mass. It may help you feel stronger and more capable in daily life.
This trial tests whether different exercise programs can improve health in people with liver cirrhosis. It uses home-based workouts via a device, which may help you stay active and feel better.
This study tests whether taking a daily drink of branched-chain amino acids (a type of protein) can help people with liver cirrhosis who have lost muscle strength and mass. It may help improve muscle size and function.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.